Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Boehringer Ingelheim receives approval for Senvelgo in Europe for diabetic cats

Ruchika Sharma24 Nov 2023 3:30 PM IST

Feline diabetes mellitus is a metabolic disorder which occurs when a cat has insufficient levels of, or an abnormal response to insulin.

Boehringer Ingelheim Jascayd receives regulatory approval for progressive pulmonary fibrosis in China

Boehringer Ingelheim expands immuno oncology portfolio with acquisition of bacterial cancer therapy specialist T3 Pharma

Ruchika Sharma24 Nov 2023 1:30 PM IST

Germany: Boehringer Ingelheim has announced the acquisition of privately-held T3 Pharmaceuticals AG, a clinical stage Swiss biotech company, for an...

Lupin secures SBTi validation for emission reduction targets

USFDA approves Lupin Bromfenac Ophthalmic Solution

Ruchika Sharma24 Nov 2023 12:30 PM IST

Bromfenac Ophthalmic Solution, 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have...

Lupin type 2 diabetes drug Canagliflozin bags USFDA tentative approval

Ruchika Sharma24 Nov 2023 11:30 AM IST

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...

GSK to start phase 3 trials of low-carbon Ventolin inhaler in 2024

Ruchika Sharma23 Nov 2023 3:26 PM IST

London: GSK plc has announced it will start Phase III trials of a low carbon version of its metered dose inhaler (MDI), Ventolin (salbutamol), using a...

Janssen seeks USFDA nod for Rybrevant plus chemotherapy for patients with EGFR-Mutated Non-Small Cell Lung Cancer who progressed on or after Osimertinib

Ruchika Sharma23 Nov 2023 2:30 PM IST

Raritan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a supplemental Biologics License ...

Blue Jet Healthcare asked to stop production after death of 11 workers in fire at its Raigad plant

Ruchika Sharma23 Nov 2023 1:30 PM IST

Alibag: Pharmaceutical firm Blue Jet Healthcare has been ordered to stop production and remove inflammable chemical goods from its premises after...

Senores Pharma to acquire two products of USFDA approved ANDAs from Teva Pharma USA

Merck to acquire Caraway Therapeutics for up to USD 610 million

Ruchika Sharma23 Nov 2023 12:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, and Caraway Therapeutics, Inc. have announced that the companies have...

Strides gets USFDA nod for Generic Suprep Bowel Prep Kit

Ruchika Sharma23 Nov 2023 11:30 AM IST

The company has set a target to launch ~ 60 new products over three years in the US.

Zydus, Dr Reddy's Labs and 1 other recall products in US over manufacturing issues

Ruchika Sharma22 Nov 2023 3:56 PM IST

New Delhi: Dr Reddy's Laboratories, Glenmark Pharma and Zydus are recalling products in the US market for manufacturing issues, according to the...

Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye Device

Medtronic shrugs off concerns over newer weight-loss drugs, raises annual forecast

Ruchika Sharma22 Nov 2023 3:04 PM IST

Medtronic raised its annual earnings forecast on Tuesday as strong sales in its surgical and diabetes units allayed concerns about the impact of...

Lupin Dapagliflozin Tablets gets tentative USFDA okay

Ruchika Sharma22 Nov 2023 1:30 PM IST

Dapagliflozin Tablets are used for the treatment of type 2 diabetes.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok